Immuneering Corp (IMRX) Unusual Options Activity Today

Checking IMRX unusual options activity helps you spot when traders are making outsized bets on Immuneering Corp before the broader market catches on. Immuneering Corp's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IMRX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IMRX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IMRX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IMRX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.

Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

Catalysts rarely arrive without a footprint, and IMRX unusual options activity is often where that footprint shows up first. Our scanner tracks Immuneering Corp's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IMRX unusual options volume on the call side or chasing put sweeps, Immuneering Corp's unusual options flow today is one click away, so put it on your radar before the headlines hit.